Inpatient healthcare burden and variables influencing hydrocephalus-related admissions across the lifespan
- PMID: 36681977
- DOI: 10.3171/2022.10.JNS22330
Inpatient healthcare burden and variables influencing hydrocephalus-related admissions across the lifespan
Abstract
Objective: The aims of this study were to quantify inpatient healthcare costs, describe patient demographics, and analyze variables influencing costs for pediatric and adult hydrocephalus shunt-related admissions in the US.
Methods: A cross-sectional study was performed using the 2019 Healthcare Cost and Utilization Project Kids' Inpatient Database (KID) and National Inpatient Sample (NIS), nationally representative weighted data sets of hospital discharges for pediatric and adult patients, respectively. International Classification of Diseases, 10th Revision, Clinical Modification and Procedure Coding System (ICD-10-CM/PCS) code filters for data extraction were queried for admission information. Age at admission was categorized into five groups (≤ 28 days, 29 days to < 1 year, 1-18 years, 19-64 years, and ≥ 65 years).
Results: In 2019, there were 36,898 shunt-related hospital admissions accounting for 495,138 hospital days and a total cost of more than $2.06 billion. Initial shunt placements accounted for 53.5% of all admissions and nearly 60% of the total cost. The median cost per admission was $22,700 and the median length of stay was 5 days. Admissions for shunt infection requiring revision had the highest median cost at $71,300 (p < 0.001) and the longest median length of stay at 25 days (p < 0.001) compared with initial shunt placements. By age, admissions that occurred in the first 28 days of life cost almost 5 times more than the median, $110,500 versus $22,700, respectively, and resulted in hospital stays that were 8 times longer than the median, 41 versus 5 days, respectively. Individuals aged ≥ 65 years accounted for 28% of the total shunt-related admissions. Almost two-thirds (65.3%) of shunt-related admissions were classified as nonelective. The median cost of nonelective procedures was double that of elective admissions, $33,900 versus $15,100, respectively (p < 0.001), and resulted in almost 5 times longer hospital stays, 9 versus 2 days, respectively (p < 0.001). Shunt-related admissions were predominantly male across all age groups (54.7%-57.4% male) except the 19- to 64-year age group. In the 19- to 64-year age group, females accounted for 51.1% of admissions. Insurance status was largely age dependent. Of all admissions, 33.1% used private insurance, 32.9% Medicare, and 27.7% Medicaid.
Conclusions: This is the first study to quantify the patient demographics and cost of hydrocephalus shunt-related admissions across the entire age spectrum. Shunt-related admissions cost the US more than $2.06 billion dollars per year and represent only a fraction of the total cost of hydrocephalus care.
Keywords: Kids’ Inpatient Database; National Inpatient Sample; hydrocephalus; shunt admissions.
Similar articles
-
Cerebrospinal fluid shunt placement in the pediatric population: a model of hospitalization cost.Neurosurg Focus. 2014 Nov;37(5):E5. doi: 10.3171/2014.8.FOCUS14454. Neurosurg Focus. 2014. PMID: 25363433
-
Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths.J Neurosurg Pediatr. 2008 Feb;1(2):131-7. doi: 10.3171/PED/2008/1/2/131. J Neurosurg Pediatr. 2008. PMID: 18352782
-
Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment.Neurosurgery. 2005;56(1):139-44; discussion 144-5. doi: 10.1227/01.neu.0000146206.40375.41. Neurosurgery. 2005. PMID: 15617596
-
Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus.J Neurosurg. 2015 Jan;122(1):139-47. doi: 10.3171/2014.9.JNS131277. J Neurosurg. 2015. PMID: 25380105 Review.
-
Comorbidities Associated With Adult Inpatient Stays, 2019.2022 Dec 15. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb–. Statistical Brief #303. 2022 Dec 15. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb–. Statistical Brief #303. PMID: 36622929 Free Books & Documents. Review.
Cited by
-
The Hydrocephalus Association Patient-Powered Interactive Engagement Registry (HAPPIER): Design and Initial Baseline Report.Clin Epidemiol. 2025 Jun 24;17:567-579. doi: 10.2147/CLEP.S526203. eCollection 2025. Clin Epidemiol. 2025. PMID: 40589494 Free PMC article.
-
Recapitulation of physiologic and pathophysiologic pulsatile CSF flow in purpose-built high-throughput hydrocephalus bioreactors.Fluids Barriers CNS. 2024 Dec 19;21(1):103. doi: 10.1186/s12987-024-00600-1. Fluids Barriers CNS. 2024. PMID: 39702203 Free PMC article.
-
Quantitative and qualitative investigation of shunt failure in an in vitro hemorrhagic hydrocephalus model.Front Bioeng Biotechnol. 2025 Jul 1;13:1591952. doi: 10.3389/fbioe.2025.1591952. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40666700 Free PMC article.
-
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice.Clin Sci (Lond). 2025 May 27;139(11):559-75. doi: 10.1042/CS20255324. Online ahead of print. Clin Sci (Lond). 2025. PMID: 40459058 Free PMC article.
-
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice.bioRxiv [Preprint]. 2024 Dec 28:2024.12.28.630625. doi: 10.1101/2024.12.28.630625. bioRxiv. 2024. Update in: Clin Sci (Lond). 2025 May 27:CS20255324. doi: 10.1042/CS20255324. PMID: 39803526 Free PMC article. Updated. Preprint.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical